CRClaudio Abel Requena-Rivera

Claudio Abel Requena-Rivera

*This is an algorithmically generated author record based on publicly available information.

Claudio Abel Requena-Rivera has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prevalence, risk factors and outcomes associated with Gestational Diabetes Mellitus according to the IADPSG and NICE criteria in Mexico

    by Rafael Violante Ortíz, Elizabeth Reyna-Beltrán, Claudio Abel Requena-Rivera, Alejandra Tavera Tapia

    En México aún no existe consenso de un criterio para el diagnóstico de Diabetes Mellitus Gestacional (DMG). El objetivo fue comparar características entre los criterios diagnósticos de DMG de la Asociación Internacional de Diabetes y Grupos de Estudio del Embarazo (IADPSG) y el Instituto Nacional para la Salud y la Excelencia Clínica (NICE) en México. Se realizó un estudio prospectivo y descriptivo en la región Noreste de México. Se evaluó prevalencia, factores de riesgo, desenlaces materno-fetales. La prevalencia de DMG fue del 44,5% por IADPSG y del 37,5% por NICE. El análisis de los factores de riesgo y los resultados tendieron a ser iguales entre los criterios; sin embargo, el uso exclusivo de los criterios IADPSG o NICE limitó el número de pacientes diagnosticadas de DMG, lo que generó un porcentaje de casos mal clasificados. Los criterios IADPSG parecen tener menos limitaciones para identificar pacientes con DMG que NICE debido a las características de la cohorte. Aunque, determinando en paralelo criterios NICE, podría ser complementario para el diagnóstico de DMG en México. Como conclusiones proponemos la valoración de ambos criterios (IADPSG y NICE) para identificar el mayor número de mujeres en riesgo de DMG. La falta de diferencias significativas en los resultados entre los criterios refleja la importancia del tratamiento oportuno para pacientes con DMG, que no se administra en un porcentaje de casos de DMG perdidos cuando solo se utiliza un criterio.


    • 2 January 2023
      • Vol. 61  (1) , 61-67
    Open Access

    [Maternal-fetal outcomes in women with gestational diabetes in an intensive control program].

    by Rafael Violante-Ortíz, Norma Lidia Fernández-Ordóñez, Claudio Abel Requena-Rivera, Salvador Sabino Mojarro-Bazán, Tania Alemán-Cabrera

    Gestational diabetes mellitus (GDM) is first diagnosed during pregnancy and it is the most frequent maternal hyperglycemia. To know fetal and maternal outcomes in an intensive control program in pregnant women with and without DMG at the Instituto Mexicano del Seguro Social (Mexican Institute for Social Security) Regional General Hospital No. 6, in Ciudad Madero, Tamaulipas. A descriptive and retrospective study, which included 800 outcomes of pregnant women between January 2009 and June 2020. Anthropometric data and pregnancy outcomes were collected. The intensive control program consisted of face-to-face consultations of 1 to 4 weeks, granted according to the degree of metabolic control, with which it was given nutritional counseling, recommendations for physical activity, and in some cases pharmacological treatment. The prevalence of GDM was 36.2%. There were no statistically significant differences between the two groups, except for respiratory distress syndrome, which was more common in GDM (9.4%, p = 0.06). Patients with GDM had a lower prevalence of macrosomy (6.1%) compared to the control group (6.6%). All women admitted to the program in the first trimester had fewer fetal and maternal complications. This study demonstrates the effectiveness and efficiency of implementing an intensive control program in women with GDM, by reducing and equalizing maternal and fetal outcomes compared to a group of women without the disease.